Clinical Pharmacy PhD, Master's Supervisor Deputy Director, Clinical Pharmacy Subspecialty, Zhongshan Hospital, Fudan University Head of Pharmacy Department, Zhongshan Hospital (Xiamen), Fudan University Shanghai "New Star of Medicine" Young Medical Talent; Young Talent of the Chinese Pharmaceutical Association; Young Talent of the Shanghai Pharmaceutical Association Scholar of the Harvard Global Clinical Scholars Research Training Program First/Corresponding author of 14 SCI papers and 10 core Chinese journal papers Principal investigator of 12 research projects, including grants from the National Natural Science Foundation of China etc. Standing Committee Member and Secretary of the Youth Committee, Therapeutic Drug Monitoring Research Committee, Chinese Pharmacological Society; Youth Committee Member, Drug-induced Diseases Committee, Shanghai Pharmaceutical Association Recipient of honors including the Top Ten "2022 Patient Safety Goal Practice Typical Cases" by the Chinese Hospital Association for pharmaceutical care case; the 2021 "Pharmacy Elite" Award by the Clinical Pharmacy Branch of Shanghai Medical Association.

Harsh Prajapati is a Research Assistant at the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) and Tata Memorial Hospital, Navi Mumbai. He holds an M.Pharm in Pharmacology from Gujarat Technological University. Harsh has contributed to multiple clinical research projects, including pharmacokinetic profiling, adverse drug reaction studies, and early-phase clinical trials in oncology.

Zhihui Song, Clinical Pharmacist in Endocrinology, Chief Pharmacist. Research Interests: Pharmaceutical care for common diseases such as diabetes, thyroid disorders, hypertension, and hyperlipidemia; Adverse reaction monitoring; Medication guidance for special populations.

Dr. Tang Suk Peng is a Senior Lecturer at the School of Medical Sciences, Universiti Sains Malaysia. Her current research focuses on the effects of chronic exposure to environmental toxicants using animal models and the study of natural products as potential therapeutic approaches.

Dr. Yasuo Tsutsumi is a Professor at the Graduate School of Pharmaceutical Sciences, The University of Osaka, Japan. Prof. Tsutsumi specializes in toxicology and public health in the field of pharmaceutical sciences. In particular, he is interested in the toxicity and safety of micro- and nanoparticles. Prof. Tsutsumi received his B.S., M.S., and Ph.D. in Pharmaceutical Sciences from The University of Osaka, Japan. He began his academic career at the Graduate School of Pharmaceutical Sciences, The University of Osaka, in the Laboratory of Pharmaceutics in 1994. Prof. Tsutsumi was promoted to Professor in 2008 at the Laboratory of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, The University of Osaka.

Dr. Ling Wei is an associate professor of pharmacology at Guangdong Pharmaceutical University. She earned her Ph.D. from Osaka University under the supervision of Prof. Yoshikatsu Kanai and completed postdoctoral training in the United States and Japan. Her research focuses on SLC transporter pharmacology and transporter-mediated drug disposition, with particular expertise in the roles of OAT1 and LAT1 in renal handling and tumor imaging. Dr. Wei elucidated the tumor-specific transport mechanism of the PET tracer 18F-FAMT and investigated molecular mechanisms underlying drug-induced nephrotoxicity, including mechanistic studies of clinically relevant transporters such as SGLT2. She has published nearly 30 peer-reviewed articles and has received competitive funding from the Japan Society for the Promotion of Science and the National Natural Science Foundation of China.

Prof. Weng‘s research focuses on natural product-based cancer drug discovery, of which the carrier path was inspired by her background as a pharmacist.

Dr. Qian Zhou received a doctorate degree in medicine from University of Occupational and Environmental Health in 2021. Presided over 1 project of the National Natural Science Foundation of China, 1 project of new teachers' research program of TJUTCM. Her main research interests lie in Chinese medicine and compound cardiovascular pharmacology, and neuropharmacology. In recent years, she has published more than 10 SCI papers, which have been cited more than 100 times.

Ms. Chahat Choudhary serves as a Demonstrator/Tutor in the Department of Pharmacology at AIIMS Rishikesh, Uttarakhand, India, specializing in pharmacological sciences, clinical research, and academic teaching. She completed her postgraduate studies in Medical Pharmacology at AIIMS Rishikesh (2018–2021). She has authored several publications on topics such as drug-related adverse pregnancy outcomes, COVID-19 clinical trials, and pharmacovigilance, including recent works in the Journal of Family Medicine and Primary Care. Her expertise encompasses in-vivo and in-vitro experiments, HPLC techniques, ADR monitoring, and pharmacovigilance, supported by certifications in Good Clinical Practice and participation in workshops on translational medicine. She is a member of the British Pharmacological Society and was awarded a bursary for an international poster presentation at EACPT 2025 in Finland. Ms. Choudhary remains an early-career researcher actively exploring the field of pharmacology.

Viktorija Erdeljić Turk, MD, PhD, is a physician and consultant clinical pharmacologist at the University Hospital Centre Zagreb, Croatia. Her career has developed across hospital medicine, academia, and regulatory science. Her main professional interests include therapeutic optimization, drug safety, rational use of medicines, and antimicrobial stewardship. She teaches medical and pharmacy students in Croatian, English, and German at the Universities of Zagreb, Rijeka, and Osijek, and has mentored many trainees in clinical pharmacology. She is an experienced clinical trialist with extensive involvement in industry- and academia-sponsored studies. She also serves as an external expert to the Croatian Agency for Medicinal Products and Medical Devices and the European Medicines Agency. Her early work with UNHCR, UNICEF, and WHO contributed to her strong commitment to socially responsible and evidence-based medicine.

Dr Ajaya Kumar Sahoo Assistant Professor Department of Pharmacology All India Institute of Medical Sciences, Bhubaneswar

Gao Zhan, female, born in 1986, graduated from Chongqing Medical University and is a member of the Communist Party of China. She primarily engages in research and practical work on pharmaceutical administration management, optimization of pharmaceutical services, and promotion of rational drug use. In recent years, she has focused on research and promotion in areas such as refined pharmaceutical administration management in medical institutions and the establishment of clinical rational drug use evaluation systems. She has authored multiple popular science articles dedicated to disseminating scientific knowledge about drug use to the public. She has successively won the Excellence Award in the Chongqing Division of MKM Cup 2024 Pharmaceutical Service Skills Competition, the Individual Excellence Award in the Second Chongqing Pharmaceutical Service Skills Competition, and the Third Prize in the First Sichuan-Chongqing Youth Medical Staff Practice Innovation Competition.

Dr. Syed Ziaur Rahman is Professor and Chairman of the Department of Pharmacology at Jawaharlal Nehru Medical College, Aligarh Muslim University (AMU), India, and Founder Director of the Centre for Advanced Study in Pharmacology at the Ibn Sina Academy, recognized as a “Centre of Excellence” by the Ministry of Ayush. He holds an MBBS and MD from AMU, Aligarh, and a PhD from the School of Medicine, Western Sydney University, Australia. Dr. Rahman has published over 200 research papers in national and international journals and has led seven major academic projects. He is a sought-after speaker, having delivered more than 200 guest lectures as a resource person. In pharmacovigilance, he has reported numerous adverse drug reactions and pioneered the field of Environmental Pharmacovigilance, coining the term “Pharmacoenvironmentology” to describe the study of therapeutic drugs and their environmental impact. His research also includes work on morphine de-addiction using medicinal plants, where he developed a modified model for moderately and severely morphine-dependent rats and extensively screened Delphinium denudatum and Myristica fragrans for protective activity against morphine-induced physical dependence. Dr. Rahman is a Fellow of the Faculty of Pharmaceutical Medicine (FFPM), Royal Colleges of Physicians, UK, and holds fellowships with the Indian Academy of Biomedical Sciences (FIABS), National Academy of Medical Sciences (FAMS), IMA Academy of Medical Specialties (FIAMS), International Medical Sciences Academy (FIMSA), and Indian Pharmacological Society (FIPS). His contributions to pharmacology have been recognized with several prestigious orations, including the Prof. M. Nasim Ansari Oration (2022), Dr. S. B. Pandey Oration (2024), and KC Singhal Oration (2025).

Puiu Olivian STOVICEK is a Habilitated Associate Professor at the Faculty of Nursing, Titu Maiorescu University of Bucharest, Romania, and an Adjunct Associate Professor at the Faculty of Psychology, University of Craiova. He is a senior physician in clinical pharmacology at the “Sf. Nectarie” Oncology Center in Craiova, where he serves as a subinvestigator in international phase I, II, and III clinical trials. He also holds certifications in palliative care and healthcare management. His main professional interests focus on integrating clinical pharmacology and psycho-oncology into a holistic approach to oncology and palliative care. An important line of his research examines the impact of oncological treatments on mental status, associated psychological symptoms, and quality of life. His academic work includes a significant number of books, book chapters, and research articles published nationally and internationally.

Ivana Šutej is an Associate Professor at the School of Dental Medicine, chair of pharmacology department at University of Zagreb. Her work focuses on dental pharmacotherapy and medication utilization, with particular emphasis on rational antibiotic prescribing in dentistry and the development of evidence-based teaching materials to strengthen students’ understanding of appropriate medication use.

Ping Lin Tsai (Luke) is a fourth-year Ph.D. student at the Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University (NCKU), Taiwan. He earned his Doctor of Pharmacy (Pharm.D.) from NCKU and specializes in human genomics, pharmacogenomics, and precision medicine. Luke’s research focuses on integrating multi-omics data to drive clinical innovation. His current work utilizes rule-based algorithms and real-world evidence to evaluate treatment patterns and survival outcomes in East Asian pancreatic cancer cohorts, specifically examining the clinical impact of TS-1 and surgical integration. A recipient of the NCKU Outstanding Student Direct Admission Scholarship, he has presented research internationally and published in the Journal of Personalized Medicine. He aims to bridge the gap between genomic research and routine clinical practice to advance precision oncology.

Yoshihiro Uesawa, PhD, is a Professor in the Department of Medical Molecular Informatics at Meiji Pharmaceutical University, Tokyo, Japan. He is a licensed pharmacist and earned his PhD in Pharmaceutical Sciences from Meiji Pharmaceutical University. His research focuses on drug safety science, computational toxicology, and the prediction of adverse drug reactions. Dr. Uesawa conducts extensive research using pharmacovigilance databases such as FAERS and JADER, as well as quantitative structure–activity relationship (QSAR) and machine-learning approaches for toxicity prediction. He has led research teams in international drug-safety modeling challenges and has published widely in peer-reviewed journals. Through his research and educational activities, he aims to advance reliable drug safety assessment and to integrate data-driven predictions into pharmaceutical education and practice.

Dr Yadav is currently serving as an Additional Professor in the Department of Pharmacology at the All India Institute of Medical Sciences (AIIMS), New Delhi. His research expertise lies in molecular and cardiovascular pharmacology, with a strong focus on elucidating novel therapeutic strategies for cardiovascular diseases. With over 18 years of rich academic and research experience, Dr Yadav has guided/guiding more than 55 postgraduate and doctoral scholars (M.Sc., M.Pharm., MD, and Ph.D.) and has published over 90 high-impact research and review articles in reputed national and international journals. Dr Yadav is the member of National Academy of Medical Sciences (NAMS) and the National Academy of Sciences, India (NASI), and has made significant contributions to the pharmacological community as the Secretary (International) of the Indian Pharmacological Society (IPS). Dr Yadav is serving as vice president of International Academy of Cardiovascular Sciences (India Section) and organised international conference (ICP-IPSCON 2024) in 2024 in AIIMS New Delhi. He has successfully executed and contributed to over 19 different research projects funded by premier agencies such as AIIMS, ICMR, DBT, and DST. In recognition of his outstanding scientific contributions, Dr Yadav has received numerous prestigious honours and awards, including the Fellowship of Indian Pharmacological Society (FIPS, 2025), Fellowship of Punjab Academy of Sciences (FAPS, 2025), Fellowship of the International Academy of Cardiovascular Sciences (FIACS, 2023), Distinguished Service Award in Cardiovascular Sciences, Certificate of Excellence in innovation from ICMR, and Prof. N.S. Dhalla Oration Award (2023), Fellowship by the Asian Pacific Society of Hypertension (2022), Pharmacy Ratna Award (UP, 2021), Dr Manjeet Singh Award, N.N. Datta Prize, and Best Research Paper Award (2018) and many others.

Tang Yaxiong, Attending Physician, Department of Gastroenterology, Tongliang District People's Hospital, Chongqing, Bachelor of Medicine. Member of the Endoscopy Group of the Digestive Diseases Committee of Chongqing Medical Association; completed advanced training at Southwest Hospital. With nearly two decades of experience in clinical practice and endoscopic procedures in gastroenterology, proficient in the diagnosis and treatment of related digestive diseases.

Chin Hang (Benson) is a PhD candidate at the Sydney Pharmacy School. His primary areas of research interest include clinical pharmacy, pharmacoepidemiology and health services research. He is also a registered pharmacist with experience in both community and hospital pharmacy.

Dr Sato is a research fellow, and working at The University of Sydney School of Pharmacy and Kolling Institute, Royal North Shore Hospital. Before starting her current position, she completed a Master of Public Health and a PhD in Pharmacy at the University of Sydney, focusing on the quality use of medicines in geriatric primary health care. She has a unique skill set, combining expertise in big data analysis, epidemiology, pharmacology, as well as clinical experience in both hospital and community pharmacy settings. Additionally, she has advanced IT skills, including programming (Python, JavaScript, R), and software (SAS, REDCap, Qualtrics).

Dr. Alahapperuma Wijesinghage Kalani Mithunika is a Lecturer in Pharmacology at the Faculty of Medicine, University of Ruhuna, Sri Lanka. She graduated with an MBBS degree from the Faculty of Medicine, University of Ruhuna in 2021 with Second Class Upper Division Honours and was awarded a Gold Medal in Pharmacology. She completed her internship in Internal Medicine and General Surgery at the National Hospital of Sri Lanka, Colombo, followed by clinical service as a Medical Officer at the Emergency Treatment Unit, District General Hospital, Hambantota, Sri Lanka. After gaining clinical experience, her interest in academia, research, and pharmacology led her to pursue an academic career in February 2025. She is a member of the Sri Lanka Association of Clinical Pharmacology and Therapeutics. Her research interests include Clinical immunology and Therapeutics, with a particular focus on immunotherapy in infectious diseases.

Dr. Gestina Aliska, Sp.FK, is a lecturer in the Department of Pharmacology and Therapeutics, Faculty of Medicine, Universitas Andalas, and a Clinical Pharmacologist at Dr. M. Djamil General Hospital, Padang, West Sumatra, Indonesia. She obtained her medical degree from Universitas Andalas and completed her Clinical Pharmacology specialist training and doctoral degree in Medical Sciences at Universitas Indonesia. Her research focuses on clinical pharmacology, with particular interests in sepsis, COVID-19, antimicrobial resistance, and pharmacogenomics. Her work emphasizes pharmacokinetic/pharmacodynamic optimization, therapeutic drug monitoring, biomarker-based therapy, and individualized treatment strategies in critically ill patients. Dr. Aliska is actively involved in funded clinical research, international scientific publications, and undergraduate and postgraduate medical education. She teaches clinical and molecular pharmacology and contributes to the development of evidence-based pharmacotherapeutic practices, with a strong commitment to advancing rational and personalized medicine in Indonesia.

Dr. Gestina Aliska, Sp.FK, is a lecturer in the Department of Pharmacology and Therapeutics, Faculty of Medicine, Universitas Andalas, and a Clinical Pharmacologist at Dr. M. Djamil General Hospital, Padang, West Sumatra, Indonesia. She obtained her medical degree from Universitas Andalas and completed her Clinical Pharmacology specialist training and doctoral degree in Medical Sciences at Universitas Indonesia. Her research focuses on clinical pharmacology, with particular interests in sepsis, COVID-19, antimicrobial resistance, and pharmacogenomics. Her work emphasizes pharmacokinetic/pharmacodynamic optimization, therapeutic drug monitoring, biomarker-based therapy, and individualized treatment strategies in critically ill patients. Dr. Aliska is actively involved in funded clinical research, international scientific publications, and undergraduate and postgraduate medical education. She teaches clinical and molecular pharmacology and contributes to the development of evidence-based pharmacotherapeutic practices, with a strong commitment to advancing rational and personalized medicine in Indonesia.

Dr. Mahesh Kumar B is currently pursuing DM in Clinical Pharmacology at the prestigious premier institute, PGIMER. His academic and research work predominantly focuses on antifungal and antimicrobial pharmacotherapy, with particular interest in therapeutic drug monitoring and pharmacokinetic–pharmacodynamic optimization in infectious diseases. He is actively engaged in advancing precision dosing strategies to improve clinical outcomes and support rational antimicrobial use in complex clinical settings.

Ivana Čegec is a medical doctor specialized in Clinical Pharmacology and Toxicology, currently working at the Department of Clinical Pharmacology, University Hospital Centre Zagreb, Croatia. She graduated from the School of Medicine, University of Zagreb, in 2007 and completed her internship at UHC Zagreb. After gaining initial experience in outpatient clinical practice, she began her specialization in Clinical Pharmacology and Toxicology in 2010 and passed the specialist board examination with distinction in 2014. Her clinical work encompasses inpatient care, day hospital services, and outpatient pharmacotherapy consultations, with a strong focus on drug hypersensitivity reactions, adverse drug reactions, drug–drug interactions, and rational pharmacotherapy. She regularly provides consultative services to other hospital departments and participates in antimicrobial stewardship programs, including the approval and monitoring of restricted antimicrobial therapies. During the COVID-19 pandemic, Dr. Čegec worked in intensive care and COVID wards and was a member of a specialized team responsible for the vaccination of high-risk patients with a history of severe allergic reactions. She has participated in several international clinical trials and has authored and co-authored numerous peer-reviewed scientific papers, book chapters, and conference presentations in the fields of clinical pharmacology, pharmacogenomics, drug allergy, and pharmacoeconomics. She also serves as one of the editors of Pharmaca, the journal of the Croatian Society of Clinical Pharmacology and Therapeutics. Dr. Čegec is currently enrolled in a doctoral program in Biomedicine and Health Sciences at the University of Zagreb, where she has defended her PhD research proposal focusing on the psychological characteristics of patients with drug hypersensitivity and nocebo responses. In addition to her clinical and research work, she is actively involved in undergraduate and postgraduate medical education and is a member of several national and international professional societies.

Giulia Mosini is a clinical pharmacologist at ASST Fatebenefratelli–Sacco. Her professional and scientific activity focuses on pharmacovigilance and clinical trials, with particular expertise in drug safety assessment, risk–benefit evaluation, and regulatory aspects of clinical research. She is involved in AIFA working meetings, contributing to the preparation of pharmacovigilance reports that are subsequently discussed within the Pharmacovigilance Risk Assessment Committee (PRAC). She has experience in the critical analysis of clinical evidence and safety data, supporting decision-making processes in hospital and regulatory settings.

Giulia Mosini is a clinical pharmacologist at ASST Fatebenefratelli–Sacco. Her professional and scientific activity focuses on pharmacovigilance and clinical trials, with particular expertise in drug safety assessment, risk–benefit evaluation, and regulatory aspects of clinical research. She is involved in AIFA working meetings, contributing to the preparation of pharmacovigilance reports that are subsequently discussed within the Pharmacovigilance Risk Assessment Committee (PRAC). She has experience in the critical analysis of clinical evidence and safety data, supporting decision-making processes in hospital and regulatory settings.

Prof. Rakesh Kumar Dixit is working as Professor and Head of Pharmacology and Therapeutics at King George's Medical University, Lucknow, India. I completed an MD in Pharmacology in 1997 and worked as a senior resident at the Postgraduate Institute of Medical Education and Research, Chandigarh. After that, I joined King George's Medical University, Lucknow, Uttar Pradesh, India in 2002 as an assistant professor. I became a Professor in 2010 and Head of the department in 2024. My passion is teaching. I am a faculty member in the medical education unit and coordinator of the Master's in Health Professional Education. I have published 129 research papers and authored 7 books. I have been president of the National Association of Pharmacology and Therapeutics and founder of the Association of Community Pharmacotherapeutics. It will be great learning to attend the WCCP 2026.

Dr. Saibal Das is a Clinical Pharmacologist and Scientist E (Medical) at the Indian Council of Medical Research – National Institute for Research in Bacterial Infections, Kolkata, India. He is also an Affiliated Researcher at Karolinska Institutet and serves as an Assistant Professor at the Academy of Scientific and Innovative Research, India, with extensive teaching and mentoring experience. His work focuses on translating research into policy, guidelines, and improved healthcare outcomes. He holds a PhD (Medical Science), DM (Clinical Pharmacology), MD (Pharmacology), and MBBS. Dr. Das has expertise in clinical trials, pharmacoepidemiology, medication safety, and evidence synthesis, with over 15 years of research experience across clinical, academic, and regulatory settings. He has served as Principal Investigator on multiple government-funded projects, including ICMR-INTENT and the Technical Resource Centre. Dr. Das has authored more than 120 peer-reviewed publications with significant citation impact (h-index 25). He is an active member of national and international scientific committees, regulatory bodies, and ethics boards, and has received numerous national and international awards, fellowships, and travel grants.

Dr Mowdharani PS is an MD Pharmacology resident at AIIMS Bhubaneswar, India. Her research interests are clinical pharmacology, dermatopharmacology, infectious and tropical diseases, with a keen interest in evidence-based medicine and clinical pharmacokinetics. The randomized controlled trial proposed for submission received an ICMR financial grant. She is proficient in biostatistical analysis using R and conducts systematic reviews, meta-analyses, and network meta-analyses using RevMan and Meta-Essentials. Her work includes a meta-analysis in the infectious disease domain, currently under communication for publication. She is actively engaged in the Pharmacovigilance Programme of India, therapeutic drug monitoring, and laboratory techniques. She has also completed an internship in the Clinical Sciences and Development Department at Kashiv BioSciences, gaining exposure to biologics development, analytical sciences, and clinical development planning. She has attended national workshops in clinical pharmacology, biomedical research, R programming, and clinical pharmacokinetic modeling, and actively contributes to academic teaching and research dissemination.

Prof. Ika Puspita Sari, MSi, PhD, Pharmacist is a distinguished pharmacologist and pharmacist with extensive expertise in pharmacology, toxicology, and clinical pharmacokinetics. She earned her Bachelor’s degree in Pharmaceutical Sciences (1995) and completed the Pharmacist Program (1998) at Universitas Gadjah Mada, Indonesia. She obtained her Master’s in Pharmaceutical Sciences in 1999 from the same university and completed a PhD in Neuroscience at Monash University in 2011, with postdoctoral research at Yale University’s Faculty of Medicine in 2010. Prof. Sari teaches a wide range of subjects, including Pharmacology and Toxicology Experimental, Pharmacoepidemiology, Minor Illness, Clinical Pharmacokinetics, Pharmacotherapy of Infection, Pharmacokinetic-Pharmacodynamics of Drugs, and Research Methodology. Her research spans pharmacotherapy, drug pharmacokinetics, and natural product neuroscience, with publications exploring topics such as the mood-boosting potential of bananas, chemotherapy regimen administration, pharmacokinetic studies of amikacin, bioanalytical methods for drug quantification, and anti-biofilm activity of ambroxol. Her work integrates rigorous experimental methods and clinical applications, contributing to both patient care and drug development.

Fita Rahmawati Ph.D is lecturer and researcher at Faculty of Pharmacy, Universitas Gadjah Mada, and Yogyakarta, Indonesia. She is head of the study program of Magister Clinical Pharmacy, Universitas Gadjah Mada since 2021 to 2025. She is a registered pharmacist and fellow of The Indonesian Pharmacist Association. She holds PhD in Clinical Pharmacy from the School of Pharmaceutical Sciences, Universiti Sains Malaysia. Fita Rahmawati has completed training in field clinical pharmacy in Samford University McWhorter School of Pharmacy and the University of Southern California School of Pharmacy USA in 2012. Previously she has experience working in a national manufacturer and pharmacy. Her work has centered around geriatric medicine, cardiovascular medicine, chemotherapy and parenteral intravenous problems. Her research has been published in some journals and conferences. She teaches pharmacotherapy, clinical pharmacy, and aseptic dispensing. She is also a guest lecturer in some private schools of pharmacy and a speaker in some seminars as well.

Dr. Surjit Singh, MBBS, MD, DM, MAMS, is Professor at AIIMS Jodhpur, India. He focuses on Clinical pharmacology services, investigator-led research, and methodological capacity building in health research. He oversees clinical and analytical pharmacokinetic responsibilities with therapeutic drug monitoring services and serves as Deputy In-charge of the Adverse Drug Reaction Monitoring Centre under the Pharmacovigilance Programme of India. He is a certified American Heart Association (AHA) BLS-ACLS Instructor. His research experience extends across Phase I to Phase IV clinical trials, with several publications in high-impact Q1 journals. He has been featured multiple times in Elsevier’s annual Top Scientists lists. In addition to routine teaching responsibilities, he is actively engaged in research capacity building for clinicians and researchers at different career stages, from senior faculty members to postgraduate scholars. His capacity-building interests include clinical trial methodology, critical appraisal of research, and synthesis of pharmacotherapeutic evidence. Thereby, he integrates his extensive background in different aspects of clinical pharmacology and research to mentor the next generation of medical professionals.

Dr. Surjit Singh, MBBS, MD, DM, MAMS, is Professor at AIIMS Jodhpur, India. He focuses on Clinical pharmacology services, investigator-led research, and methodological capacity building in health research. He oversees clinical and analytical pharmacokinetic responsibilities with therapeutic drug monitoring services and serves as Deputy In-charge of the Adverse Drug Reaction Monitoring Centre under the Pharmacovigilance Programme of India. He is a certified American Heart Association (AHA) BLS-ACLS Instructor. His research experience extends across Phase I to Phase IV clinical trials, with several publications in high-impact Q1 journals. He has been featured multiple times in Elsevier’s annual Top Scientists lists. In addition to routine teaching responsibilities, he is actively engaged in research capacity building for clinicians and researchers at different career stages, from senior faculty members to postgraduate scholars. His capacity-building interests include clinical trial methodology, critical appraisal of research, and synthesis of pharmacotherapeutic evidence. Thereby, he integrates his extensive background in different aspects of clinical pharmacology and research to mentor the next generation of medical professionals.

Dr. Surjit Singh, MBBS, MD, DM, MAMS, is Professor at AIIMS Jodhpur, India. He focuses on Clinical pharmacology services, investigator-led research, and methodological capacity building in health research. He oversees clinical and analytical pharmacokinetic responsibilities with therapeutic drug monitoring services and serves as Deputy In-charge of the Adverse Drug Reaction Monitoring Centre under the Pharmacovigilance Programme of India. He is a certified American Heart Association (AHA) BLS-ACLS Instructor. His research experience extends across Phase I to Phase IV clinical trials, with several publications in high-impact Q1 journals. He has been featured multiple times in Elsevier’s annual Top Scientists lists. In addition to routine teaching responsibilities, he is actively engaged in research capacity building for clinicians and researchers at different career stages, from senior faculty members to postgraduate scholars. His capacity-building interests include clinical trial methodology, critical appraisal of research, and synthesis of pharmacotherapeutic evidence. Thereby, he integrates his extensive background in different aspects of clinical pharmacology and research to mentor the next generation of medical professionals.

Milan is a Post-Doctoral Research Fellow in the Department of Medicine at the University of Otago, Christchurch. His research focuses on leveraging routinely collected healthcare data to enhance electronic clinical decision support (CDS) for hospital medication prescribing. He has a particular interest in CDS alerts, their impact on prescribing behavior and clinical outcomes, and strategies to reduce alert fatigue. He also has a keen interest in prescribing education.

Milan is a Post-Doctoral Research Fellow in the Department of Medicine at the University of Otago, Christchurch. His research focuses on leveraging routinely collected healthcare data to enhance electronic clinical decision support (CDS) for hospital medication prescribing. He has a particular interest in CDS alerts, their impact on prescribing behavior and clinical outcomes, and strategies to reduce alert fatigue. He also has a keen interest in prescribing education.

Prof. Liqin Tang is a leading researcher at the First Affiliated Hospital of USTC, whose research endeavors have yielded groundbreaking contributions to diabetes and its complications. She has dedicated substantial efforts to exploring the pathogenesis of diabetes, unraveling intricate mechanisms, and identifying promising drug treatment targets. Beyond diabetes research, professor Liqin Tang is dedicated to pioneering innovative strategies for cancer diagnosis and therapy, ranging from nanomaterial-based diagnostic probes to targeted drug delivery systems.

Dr Arlene Taylor is an independent consultant with interests in precision medicine, pharmacogenomics, and evidence-based solutions that improve health (and other) outcomes for all members of society. With a background in clinical medicine, and extensive experience in associated fields, Dr Taylor has committed herself to applying her skills to create meaningful change.

Lara Vranić was born on 3 September 2000 in Zagreb. She completed her primary education at Pantovčak Primary School and her secondary education at the VII Gymnasium in Zagreb. In 2019, she enrolled at the School of Dental Medicine, University of Zagreb, where she graduated in June 2025. During her studies, she actively participated in the work of student associations and projects. From her second year of study, she has been working as a dental assistant at the Lani Dental clinic, where she has gained valuable clinical experience alongside her academic progress. She has been a member of the Council of the School of Dental Medicine since her fourth year of study. In 2022, she joined the organizing committees of the Oral Cancer Week project, the Virtual World Congress of Dental Students, the Section for Dental Traumatology, and the Section for Orthodontics. Since that year, she has also been actively participating in scientific congresses. In 2023, she served as President of the Organizing Committee of the Virtual World Congress of Dental Students, and in 2024 and 2025 she led the Organizing Committee of Dental Trauma Days, further highlighting her leadership and organizational skills. In 2023, she was appointed Student Ombudsperson of the School of Dental Medicine, where she actively advocates for students’ rights. In the academic year 2023/2024, she worked as a teaching assistant (demonstrator) at the Department of Fixed Prosthodontics. For her engagement and contributions, she received two Rector’s Awards for socially beneficial work in the academic years 2021/2022 and 2022/2023. In 2025, she was the recipient of the prestigious CED-IADR Robert Frank Undergraduate Award.

The presenting author is a PhD candidate in exercise Rehabilitation with a Master’s degree in Physical Therapy, specializing in the therapeutic application of exercise for chronic disease management, with a focused emphasis on Type 2 Diabetes. Clinical experience includes assessing patient functional capacity and designing individualized, evidence-based exercise prescriptions in outpatient settings. In addition, the author focuses on the relationship and impact of exercise on disease improvement and medication usage in populations with chronic diseases.

Dr. Jiao Xie is the Deputy Director of the Department of Pharmacy at The Second Affiliated Hospital of Xi'an Jiaotong University. With experience in hospital pharmacy management and clinical research, Dr. Xie specializes in antimicrobial stewardship, therapeutic drug monitoring, and the application of pharmacometric modelling to optimize drug therapy.

Wenwen Zhang is an Associate Researcher at the Research Institute of Gynecology and Obstetrics, Tianjin Central Hospital of Gynecology and Obstetrics, China. Her research focuses on lipid metabolism and the molecular mechanisms underlying endometrial epithelial lesions, with particular emphasis on early diagnostic biomarkers and pharmacological strategies for fertility-sparing treatment of endometrial cancer. She has published 21 peer-reviewed articles in Chinese and international journals, with a cumulative SCI impact factor of 97.6, including first-author publications in international journals. Her research has been supported by the National Natural Science Foundation of China and regional funding programs. She has presented her work at multiple national and international conferences and was recognized as a Tianjin Young Medical Talent.

Dr. Lei Zhang is a professor of School of Pharmacy at Anhui Medical University, Hefei, China. Dr. Zhang received PhD from Anhui Medical University (2008) and acted as visiting scholar at Morehouse School of Medicine for academic communication (2017-2018). She was selected into the list of the world's top 2% scientists released by Stanford University in the US in 2020 and 2025, leading talents of Anhui province's “Special Support Plan” in 2023, the esteemed designation of Academic Leader of Anhui Province in 2024. Dr. Zhang has been actively investigating the mechanism of liver damage/repair, focusing on the roles of epigenetic, cell metabolism and protein homeostasis in the progression of liver fibrosis. She is also interested in searching for degradation of key proteins involved in epigenetic "reprogramming" during chronic liver diseases. Dr. Zhang got 3 research grants supported by National Natural Science Foundation of China.

With a keen interest in geriatric medicine, research and education, I am currently undertaking my Doctor of Philosophy at The University of Sydney under main supervisor Professor Sarah Hilmer. My research centres round co-designing digital solutions for older people, that optimises medication management and promotes collaboration with health care practitioners.

Vera Battini is a pharmacoepidemiologist at Università degli Studi di Milano, Italy. Her research focuses on the use, safety, and effectiveness of medicines in real-world settings, with particular interest in drug repurposing, metabolic pathways, and frail patients. She has experience in the analysis of large healthcare databases, observational study design, pharmacovigilance analyses, and systematic reviews and meta-analyses.

Prof. Dr. Petra A. Thürmann, MD, is Director of the Philipp Klee-Institute of Clinical Pharmacology, Helios University Clinic Wuppertal, Germany. Since 2021 she is Vice-President of the University of Witten/Herdecke. After studies of Medicine at the Johann Wolfgang Goethe-University in Frankfurt/Main she received a board certified specialist’s degree in Clinical Pharmacology in 1992 and PhD (Habilitation) in 1997. In 1997 appointment at the HELIOS University Clinic in Wuppertal and 1998 at the University of Witten/Herdecke. Petra Thürmann was member of the Executive Committee of IUPHAR between 2004 and 2018. She is member of the Drug Commission of the German Medical Association, served from to 2011 until 2023 at the Advisory Council on the Assessment of Developments in the Health Care System (German Ministry of Health) and belongs since 2023 to the Expert Advisory Council “Health and Resilience” of the Federal Government of Germany. Her research interest is focused on geriatric pharmacotherapy (e.g. PRISCUS list), drug therapy safety as well as gender medicine.

Prof. Dr. Petra A. Thürmann, MD, is Director of the Philipp Klee-Institute of Clinical Pharmacology, Helios University Clinic Wuppertal, Germany. Since 2021 she is Vice-President of the University of Witten/Herdecke. After studies of Medicine at the Johann Wolfgang Goethe-University in Frankfurt/Main she received a board certified specialist’s degree in Clinical Pharmacology in 1992 and PhD (Habilitation) in 1997. In 1997 appointment at the HELIOS University Clinic in Wuppertal and 1998 at the University of Witten/Herdecke. Petra Thürmann was member of the Executive Committee of IUPHAR between 2004 and 2018. She is member of the Drug Commission of the German Medical Association, served from to 2011 until 2023 at the Advisory Council on the Assessment of Developments in the Health Care System (German Ministry of Health) and belongs since 2023 to the Expert Advisory Council “Health and Resilience” of the Federal Government of Germany. Her research interest is focused on geriatric pharmacotherapy (e.g. PRISCUS list), drug therapy safety as well as gender medicine.

Megan Clark is a PhD candidate and clinical pharmacist specialising in neonatology, with over a decade of experience in neonatal intensive care. Since 2020, she has led her organisation’s neonatal clinical pharmacy service and contributed to the national standard of practice for Women’s and Newborn Health pharmacists through Advanced Pharmacy Australia’s Women’s and Newborn Health Leadership Committee. Her work in developing neonatal emergency medication resources and pharmacy services for high-risk pregnancies has been recognised with the William Mercer Young Achiever Award and the Society of Hospital Pharmacists of Australia Early Career Pharmacist of the Year Award (both 2021). Megan’s PhD focuses on population pharmacokinetics in preterm and term neonates, using real-world data to optimise medication use and improve outcomes in this vulnerable population.

Matt Doogue is a clinical pharmacologist passionate about clinical pharmacology principles in patient care. He has clinical and academic roles in clinical pharmacology and as a physician in a busy acute general medicine service. His interests include quality use of medicines, adverse drug reactions, clinical decision support, and therapeutic drug monitoring.

Miss Nileshni Fernando is a research officer at the Centre for Medicine Use and Safety at Monash University where she contributes to research aimed at improving the quality and safety of medication in people living with dementia. Miss Fernando has completed a Bachelor of Biomedical Science (Honours) and is now completing a Graduate Diploma of Psychological Sciences (Advanced). Her research interests centre on co-design processes, qualitative research methodology and meaningful engagement with individuals who have lived experience.

Elizabeth has been awarded a Monash University research scholarship to undertake research in the deprescribing field with Dr Emily Reeve and Dr Shin Liau at Monash University, Centre of Medicine Use and Safety. With a background in Commerce and Biomedical Science, she developed a strong foundation in pharmacology and health economics, which aided her transition into the healthcare field. Throughout her pharmacy studies, she has garnered an interest in drug development and medication safety. Elizabeth is currently an intern pharmacist at Grampians Health Ballarat and is excited to learn from an array of pharmacists of various expertise and backgrounds, as well as continue to pursue her interest in research during her intern year.

Sungpil Han, M.D., Ph.D., is an Assistant Professor in the Department of Pharmacology at the Catholic University of Korea, College of Medicine. Combining clinical expertise with advanced pharmaceutical research, he also serves as a Director and Program Manager at AIMS BioScience, where he bridges the gap between academic innovation and drug development strategy. Dr. Han is a specialist in pharmacometrics, with extensive experience in pharmacokinetic and pharmacodynamic (PK/PD) modeling and simulation. His current research focuses on the cutting-edge application of Microphysiological Systems (MPS) to predict human pharmacokinetics. By integrating ADME (Absorption, Distribution, Metabolism, and Excretion) aspects and Drug-Drug Interaction (DDI) evaluations, his work aims to develop robust alternatives to animal testing. An active contributor to the global regulatory science community, Dr. Han is dedicated to advancing pharmacology education and fostering international collaborations to streamline the transition from preclinical research to clinical success.

Dwi Aris Agung Nugrahaningsih, M.D., M.Sc., Ph.D is a lecturer in the Department of Pharmacology and Therapy, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada. She earned her Ph.D from the Faculty of Medicine, Kobe University, Japan in 2013. Her research focuses include drug discovery and development, pharmacogenomics and toxicogenomics, as well as stem cell research and its derivatives for therapeutic applications and disease modeling. She holds key leadership roles in research infrastructure, having served as the former Head of the Integrated Research Laboratory and Animal Laboratory Coordinator at FK-KMK UGM. She is also actively involved in the scientific community as the Secretary of the Indonesian Society of Human Genetics (InaSHG). Dr. Nugrahaningsih is the principal investigator of numerous studies, including in vitro and in vivoresearch on antidiabetic and antihypertensive herbal compounds, clinical trials and observational studies on COVID-19 treatment, and is a member of the SARS-CoV-2 genomic surveillance team. Her specific expertise in pharmacogenomics encompasses the analysis of genetic variations in drug response, while in stem cell research, she is involved in studies on stem cell differentiation for disease modeling and drug toxicity screening.

Dr. D. Figueredo received her B.A. degree (1995, Biochemistry) from Faculty of Biology, Havana University, Cuba, and both her MSc (1995, Biomedicine) and PhD (1999 Pharmaceutical Sciences) degree from National Center for Scientific Research in Havana, and most of the results were done in the Department of Toxicology at the Free University in Amsterdam. Postdoctoral training in Molecular Toxicology and pharmacology was completed at the Faculty of Pharmacy in Toronto, Canada. She has been referee of scientific journals related with pharmacology. Other previous academic appointments include lecturer in different international meeting. She has been the recipient of National Award of Pharmacology twice from the Cuban Pharmacology Society. She worked as Expert for the evaluation of preclinical platform in South Africa. (CSIR). She is the focal point to the World Health Organization network for regulatory cooperation of herbal medicines (IRCH). She is a membership committee of International Union of Pharmacology (IUPHAR). She is the secretary of Latin-American Network of Pharmacogenetic. She is currently the Vice president of Cuban Pharmacology Society. At present she works in the Cuba Regulatory Agency as senior researcher, she is in charge of the evaluation of safety and efficacy of traditional, integrative and complementary medicines for registering. Dr. Remirez research is described in over 60 published research reports.

Julia Rosenqvist is a doctoral researcher at the University of Helsinki. She earned her Master of Science degree in Molecular Techniques in Life Science through a joint Master’s program by Karolinska Institutet, Stockholm University, and KTH Royal Institute of Technology. Her research focuses on the pharmacogenetics of fluoropyrimidine anticancer drugs, with the goal of enhancing personalized medicine by exploring the effects of genetic variants and other individual factors. In addition to pharmacogenetics, her key research interests include pharmacokinetic modeling.

Dr Arlene Taylor is an independent consultant with interests in precision medicine, pharmacogenomics, and evidence-based solutions that improve health (and other) outcomes for all members of society. With a background in clinical medicine, and extensive experience in associated fields, Dr Taylor has committed herself to applying her skills to create meaningful change.

Sihan Wang is a PhD candidate in the Department of Molecular Medicine and Pathology at the University of Auckland, New Zealand, supervised by Professor Nuala Helsby. Her research sits at the intersection of pharmacogenomics and clinical pharmacology, addressing the urgent need for comprehensive pre-therapeutic screening in oncology. Building on her Master’s research into urinary biomarkers for 5-fluorouracil toxicity, Sihan’s doctoral work investigates the broader catabolic disposition of fluoropyrimidines. Her research challenges the conventional focus on anabolic-driven toxicity in mitotic tissues, exploring how alternative metabolic pathways may contribute to adverse effects in non-mitotic organs, such as the heart. This is critical, as current management often requires the cessation of treatment when toxicities arise, leaving patients without effective oncological control. By utilising LC-MS methods to characterise the pharmacokinetic behaviour of 5-fluorouracil in clinical cohorts, Sihan aims to identify endogenous biomarkers for metabolic phenotyping. Her work seeks to establish a pre-therapeutic screening strategy to identify individuals at risk of varied fluoropyrimidine toxicities, thereby personalising treatment and enhancing patient safety. Sihan is interested in pursuing a career in clinical research.

Hong-Wen Wang is a PhD student at the College of Medicine, National Cheng Kung University, Taiwan. His research focuses on the genetic and molecular mechanisms underlying complex diseases, integrating genome-wide association studies, transcriptome analyses, single-cell analysis, and causal inference approaches such as Mendelian randomization. He combines multi-omics data integration with experimental validation in cellular models to identify biologically meaningful risk factors, therapeutic targets, and repurposable drug candidates, aiming to translate genomic discoveries into clinically actionable insights. Parkinson’s disease (PD) currently serves as one of his primary disease models for investigating neurodegenerative mechanisms and translational applications. Through integrative and translational research, he seeks to elucidate disease heterogeneity and uncover modifiable pathways that may contribute to improved precision medicine approaches across neurological disorders.

Dr. Vycke Yunivita is a Lecturer and Pharmacologist at Universitas Padjadjaran, Indonesia, specializing in clinical pharmacology and pharmacogenomics. She earned her Doctor of Medicine (S3) from Universitas Padjadjaran in 2020, with a research focus on pharmacokinetics, drug metabolism, and genetic determinants of drug response, particularly in tuberculosis and metabolic diseases. Her expertise in bioanalytical method development—including the validation of UPLC-MS/MS for drug quantification—and her published work on genetic polymorphisms (e.g., ABCB1, CYP2E1) and pharmacokinetic profiling provide a strong foundation for her current research presented here. This poster on OCT1 polymorphism and metformin pharmacokinetics in T2DM patients extends her pharmacogenomic investigation into the field of diabetes, applying similar translational approaches to understand how genetic variations influence drug transport, exposure, and therapeutic outcomes. Through this work, Dr. Dewi continues to bridge pharmacogenomics with personalized medicine, aiming to optimize drug therapy based on genetic profiling in diverse patient populations.

Seeking to advance my academic and clinical career in a leading medical institute through a higher faculty role that fosters excellence in teaching, cutting-edge research, and quality patient care, while continuously enhancing my contributions to medical education and innovation.

Mark D. Berry holds a BSc (Hons.) in Pharmacology from the University of Sunderland and a PhD in Neuropsychiatry from the University of Saskatchewan. He is currently the Head of the Department of Human Biosciences at Memorial University of Newfoundland. For the past 35 years, his research has focused primarily on the role of trace amines and their subsequently identified GPCRs (Trace Amine-Associated Receptors) in cellular regulation. More recently, stemming from a comprehensive curriculum review that led to the development of the first undergraduate Human Biosciences programme in Canada, he has become increasingly interested in pedagogical aspects, in particular the changing function of undergraduate education and the development of more student-centric curricula.

Brad Broughton is the Head of Teaching and a Lab head within the Department of Pharmacology at Monash University. He co-leads the Cardiovascular and Pulmonary Pharmacology Group and has >20 years’ experience in cardiovascular research. For the past 13 years, Brad has played an active role in undergraduate teaching in Pharmacology, Biomedical Science and Medicine, and is dedicated to advancing innovative, evidence‑based teaching. Brad’s pedagogical approach is to create engaging learning environments that foster critical thinking to enhance student understanding of complex pharmacological concepts.

Dr Suzanne Caliph is a Senior Lecturer in the Faculty of Pharmacy and Pharmaceutical Sciences at Monash University, Australia. She is the Academic lead for the Graduate-Entry Pharmacy pathway and co-leads the Faculty's Education Research themed Skills and skill assessment. She serves as Secretary for Pharmaceutical Education and Workforce Development within FIP Western Pacific Pharmaceutical Forum and is an Executive member of the FIP-UNESCO UNITWIN Centre for Excellence in Western Pacific Region. A practising pharmacist serving culturally and socially diverse communities, she mentors early career pharmacists, interns, and students. She is recognised with several educational excellence awards, including Australian Awards for University Teaching. Her education research focuses on pharmacy professional skills and workforce advancement through technology enhanced, pedagogy driven learning.

Dr. Kumud Chapagain is an Associate Professor of Clinical Pharmacology with extensive experience in teaching, research, and mentorship. She earned her MD from Tribhuvan University, Nepal (Gold Medalist), and MBBS from the University of Science and Technology Chittagong, Bangladesh (First Position). She has completed specialized research training through the Global Clinical Scholars Research Training (GCSRT) at Harvard Medical School, the Principles and Practice of Clinical Research (PPCR) at Harvard Medical School and Harvard T. H. Chan School of Public Health, and the FAIMER Fellowship program, and currently serves as a Teaching Assistant in the PPCR program. Her research focuses on pharmacoepidemiology, medication adherence, quality use of medicines, real-world medication use, and medicine safety. She is an Early Career Editorial Board Member of Biomedicines (MDPI).

Yu-Feng Chu is a pharmacist at Kaohsiung Veterans General Hospital, known for being proactive, detail-oriented, and calm under pressure—skills strengthened through time-sensitive decision-making in the emergency department. She graduated from the Department of Pharmacy at Chia Nan University of Pharmacy and Science and is currently pursuing a part-time master’s degree in pharmacy at Kaohsiung Medical University. Yu-Feng completed PGY training at Kaohsiung Veterans General Hospital, obtained her P2 certification, and qualified as a preceptor. She also undertook comprehensive sterile compounding training, gaining hands-on experience with chemotherapy drugs, TPN, and PCA, with a strong focus on accuracy and quality assurance. She now works night shifts in the emergency department, providing outpatient, emergency, and inpatient pharmacy services, including dispensing, clinical review, and patient counseling. Her involvement in methadone maintenance treatment and emergency home care has further broadened her understanding of pharmacists’ roles in public health. She remains committed to continuous professional growth and improving healthcare outcomes.

Prof Werner Cordier, a Professor at the Department of Pharmacology at the University of Pretoria obtained his PhD in Pharmacology in 2016, and National Research Foundation Y2-rating in 2022. His biomedical research focuses on using advanced cell culture models to elucidate molecular factors that facilitate chemoresistance and dormancy in cancer so that better drug development platforms can be established for nanomedicine and indigenous knowledge systems. He has published 35 papers, with a diverse range of students graduated under his (co-)supervision (39 Honours; 11 Masters; 3 Doctoral). Apart from his biomedical research, he has completed a Postgraduate Certificate in Higher Education, the Sub-Saharan Africa Regional Institute of FAIMER’s health professions education fellowship, and a second PhD in Curriculum and Instructional Design and Development with a focus on aligning pharmacology education with health and care workforce competencies to ensure fit-for-purpose graduates. Given his involvement in the health professions education community, Prof Cordier also serves as Faculty member of the Association for Health Professions Education and Leadership and Associate Editor on the African Journal for Health Professions Education. Prof Cordier is passionate about capacitating budding researchers within the biological and educational spheres of pharmacology, with a fervent belief that tangible changes within the world will only be achieved when graduates are capable of competently entering the workforce to contribute to the challenges our communities are facing.

Cara de Moura-Cunningham has recently completed her MSc in Pharmacology at the University of Pretoria and is actively exploring PhD research opportunities in health professions education. She is a Teaching Assistant in the Department of Pharmacology and is involved in establishing the Academic Education Office (AEO) within the department. Her work focuses on quality assurance processes, the development and implementation of standard operating procedures, and strengthening educational governance to support continuous improvement in health professions education. Her academic interests include educational systems, evidence-based approaches to teaching and learning in the health sciences, and the use of artificial intelligence to enhance academic workflows, support educators, and improve the lived experience of academics.

Sheila Doggrell joined ASCEPT in 1978. She has presented at many scientific meetings of ASCEPT in NZ and Australia (and organised a few). Sheila is presently a Life Member of ASCEPT. She was awarded a DSc from Southampton, England) for her research in experimental pharmacology in 1997. She has received both the IUPHAR Education Section Teaching Excellence award and the ASCEPT Teaching Excellence award. In retirement, Sheila has an Adjunct position at Griffith University. She continues with scholarly writing (mostly opinions on recent clinical trials) and the education research.

Dr Christine Edmead is a Senior Lecturer and Director of Studies for Pharmacology at the University of Bath. She has led on the development of innovative and engaging strategies for the delivery of a practical and research-focused curriculum. Her work has included strategies to enhance group working, utilising a flipped approach to learning and encouraging application of knowledge through problem-based case studies. Her current projects are focused on active learning approaches to consolidate knowledge and skills. Her enthusiastic and engaging approach in the classroom, support of colleagues in developing their practice and her approach to curriculum design led to a NTF award (2015) and the BPS Zaimis Prize (2023). She sat on the BPS Education and Training Committee for six years and has presented at several Pharmacology conferences. She was personally commissioned to develop self-test web-based resources to accompany the 9th and 10th editions of Rang and Dale Pharmacology.

Lynette was part of a nation-wide team that secured funding from the Australian Learning and Teaching Council (ALTC) for a project entitled “Ensuring quality graduates of Pharmacology”. She has developed a program in responsible conduct in learning and research that is now embedded within Pharmacology and Medical Research Honours curricula. Lynette led the development and implementation of the multi-disciplinary ethics unit, Social Responsibility in Action SCIE2100 and a Minor in Applied Ethics. Lynette developed the ASCEPT Mentoring Program and has received the ASCEPT Teaching Excellence Award. She is an active member of the ASCEPT Education Forum, having previously served as Chair. Lynette collaborated with ASCEPT colleagues to define the core concepts in Pharmacology. She is a Senior Fellow of the Higher Education Academy. Lynette is an active member of the IUPHAR-Education Section, where she is a Councillor and Online Meetings Steering Group Member-at-Large. As an expert group member of the core concepts of pharmacology, she collaborates with pharmacology educators globally to develop and validate concept inventories.

Dr. Karim Ibrahim is a Mitacs Elevate Postdoctoral Fellow at the University of Ottawa. He has more than ten years of research experience in neuropharmacology and cardiovascular pharmacology, with multiple peer-reviewed publications on disease pathology mechanisms and therapeutics. He is currently leading a Canada-wide initiative with the Canadian Society of Pharmacology and Therapeutics (CSPT) to define core competencies for pharmacology programs and develop EDIDA-based training modules for educators. In addition to his research work, Karim possesses experience in curriculum development, teaching, and mentorship in both Canadian and international contexts.

Jennifer Irvine is an education-focused lecturer in the Department of Pharmacology at Monash University.

Marina is a mid-career academic from a culturally and linguistically diverse (CALD) background and a primary carer for an adult with a disability. She earned her PhD in Molecular Pharmacology from Macquarie University, Sydney. Passionate about teaching, Marina strives to create an inclusive and welcoming environment for all students. She is eager to contribute to initiatives that mitigate biases and foster equitable opportunities.

Dr. Nilushi Karunaratne is a dynamic and award-winning educator specialising in skill-based instruction and innovative practices. In 2017 she was awarded a Faculty Citation for Outstanding Contribution to Student Learning and received a Monash university Vice-Chancellor’s Citation in 2018. Nilushi’s education research centers on teamwork and resilience skill-based training. Her expertise in and dedication to skill-based education were recognised in 2021, when she received the ASCEPT Gillian Shenfield Early Educator Award and more recently, was awarded the IUPHAR Education Section Outstanding Early Career Educator Award in 2023. Nilushi is a driver of community growth and development as evidenced by her leadership in the Faculty’s flagship Skills Coaching Program for first year students from 2019 to 2022, and by co-creating the Parkville International and Exchange Students (PIES) Program. Nilushi has also recently been appointed as an IUPHAR Education Councillor and is Co-Deputy for the Higher Education Research and Development Society of Australasia (HERDSA) Victoria Branch.

Dr. Nilushi Karunaratne is a dynamic and award-winning educator specialising in skill-based instruction and innovative practices. In 2017 she was awarded a Faculty Citation for Outstanding Contribution to Student Learning and received a Monash university Vice-Chancellor’s Citation in 2018. Nilushi’s education research centers on teamwork and resilience skill-based training. Her expertise in and dedication to skill-based education were recognised in 2021, when she received the ASCEPT Gillian Shenfield Early Educator Award and more recently, was awarded the IUPHAR Education Section Outstanding Early Career Educator Award in 2023. Nilushi is a driver of community growth and development as evidenced by her leadership in the Faculty’s flagship Skills Coaching Program for first year students from 2019 to 2022, and by co-creating the Parkville International and Exchange Students (PIES) Program. Nilushi has also recently been appointed as an IUPHAR Education Councillor and is Co-Deputy for the Higher Education Research and Development Society of Australasia (HERDSA) Victoria Branch.

I have worked in the field of Pharmacology and Toxicology since 1980, initially in the pharmaceutical industry, and for the last 30+ years in academia. Each year I teach to a range of undergraduate and postgraduate programmes in Pharmacology using a breadth of pedagogical modalities have been tailored to the different student groups, with appropriate assessment strategies. I have a number of postgraduate teaching qualifications and have received several teaching excellence awards. My research has been acknowledged by the award of a D.Sc. (published work) in 2013, and currently have a h index of 39 (Web of knowledge).

Shivank Khare BSc (Hons) - Imperial Medical Student - Medical Cannabis Research Group, Department of Surgery and Cancer, Imperial College London, London, UK

Dr Jennifer Koenig is Associate Professor in Pharmacology at the University of Nottingham, U.K where she is the Pharmacology lead for the Graduate Entry Medicine course and lead for Equity, Diversity and Inclusion in the School of Medicine and adviser for students with disabilities. She is a Senior Fellow of the Higher Education Academy, Fellow of the British Pharmacological Society, member of the BPS Education and Training Committee, a Councillor for IUPHAR-Education Section and Co-Chair of the Online Meetings Steering Group. After a PhD at the University of Cambridge, UK, Jenny’s research focussed on using mathematical models to understand receptor internalisation and recycling for which she won the first IUPHAR receptor mechanisms Research Award in 1998. Since 2004 she has focussed on education and developed projects in mathematics education, secondary school science curriculum, pharmacology education, strategies for inclusive teaching and assessment and ethnicity in the medical curriculum.

Tan Mingdeng serves as the Director of Teaching in the Department of General Practice at Chongqing University Affiliated Three Gorges Hospital and a supervisory expert at the same institution. In 2018, he was appointed as a Supervisory Expert in General Practice by Chongqing Municipality. Currently, he holds the positions of Vice Chairman of the General Practice Committee for Health Promotion and Health Education in Chongqing Municipality and Standing Committee Member of the General Practice Committee of the Chongqing Community and Rural Health Association.

Patricia Jiefei Yu is a PhD candidate in pharmacy practice at University of Sydney, where her research focuses on optimising medication management and healthcare utilisation in people with dementia.

Lianqiu Wu, Professor of Chinese Academy of Medical Sciences and Peking Union Medical College Major in Anti-inflammatory Immunopharmacology

Yichao Xu is an Associate Chief Pharmacist and Master’s Supervisor. He serves as a Youth Committee Member of the Clinical Trial and Ethics Branch, Zhejiang Medical Association. As a key project, he participated in the National Science and Technology Major Projects during the 12th and 13th Five-Year Plans for new drug clinical evaluation platform construction. He was a main contributor winning the third prize (Intelligent Service Track) in the 2nd National Digital Health Innovation Application Competition – Medical AI Theme. He leads 5 research projects including a NSFC Young Scientist Fund, has published over 20 SCI papers, with 9 as first/corresponding author.

Chen Lin, Attending Physician in the Department of Anesthesiology, with 20 years of clinical experience. Specializes in various anesthesia techniques including general anesthesia, combined spinal-epidural anesthesia, and regional nerve block anesthesia, with particular expertise in the use of ultra-fine lumbar puncture needles and ultrasound-guided nerve blocks for limb regions.

Lu Wang, Chief Pharmacist and Secretary of the Clinical Trial Institution at The Second Affiliated Hospital of Zhejiang University School of Medicine. I have long been engaged in clinical trial management and clinical pharmacology research of innovative drugs, with rich experience in early clinical development. I have participated in more than 20 Phase I clinical trials and bioequivalence trials, and am proficient in quantitative pharmacological methods including pharmacometric modeling and simulation.

My name is Georgia Tonkin, and I am an Honours student at the University of Sydney under the supervision of A/Prof Sophie Stocker. My research focuses on CYP2C19 testing to guide clopidogrel prescribing in patients undergoing PCI. I have a strong interest in pharmacogenomics and the clinical applications of precision medicine.

Ruby is a pharmacist and PhD student from the School of Pharmacy at the University of Sydney. Her research focuses on the implementation of pharmacogenomics into routine clinical care to optimise medication therapy, improve patient safety, and enhance treatment outcomes.

Second-year pharmacology resident, interested in clinical pharmacology, pharmacogenetics and therapeutic optimization.

Nell Hudson is a pharmacology Honours student at the University of Sydney. Under the supervision of A/Prof Sophie Stocker, her current research focuses on implementing CYP2C19-guided antiplatelet therapy in patients who have undergone a percutaneous coronary intervention. She has a strong interest in pharmacogenomics and precision medicine.